Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by 1stockwatcheron Apr 05, 2021 4:51pm
123 Views
Post# 32938835

RE:RE:.15

RE:RE:.15From a distance, and like all shareholders really blinded to what is going on at MDX, I think the way to drive the utilization through Dermatologists and Plastic Surgeons - that will be who cuts out the melanomas. I recognize that this is just for Canada because every jurisdiction is different. 

Since we have no information from Medx we don't know what the process will be to get a scan and  generate enough money to cover all the costs. Pharmacy,Doctors, MDX, 

My thought is that they will need to get the Specialists to require a scan for early assessment prior to accepting the referral (not sure who they think will do the referral)

For that you would need to get acceptance by the non-academic Dermatologists who see patients. They will "educate" the family Docs about what it is and why it is needed.  Unfortunately I've seen  very little evidence that Dermatologist are supportive or even aware of Dermsecure.  How they go from pharmacy to Dermatologist has not been fleshed out for shareholders.
<< Previous
Bullboard Posts
Next >>